Drawing for CONGENICA

USPTO serial 86947101

CONGENICA

Reviewed by CopyMark Law Group

Reg. 5159172Status 702Renewal
Filing date
Status date
Registration date
Mar 14, 2017
Examiner
TAYLOR, DAVID T
Law office
TMO LAW OFFICE 112

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CONGENICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $2,600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frank S. Benjamin

Frank S. Benjamin Dentons US LLPP. O. Box 1302DENTONS US LLPChicago, IL 60604

Goods and services

ClassDescriptionStatusFirst use
009Computer platform software for use in database management, genome sequencing, annotation, interpretation and reporting, medical diagnosis and treatments, drug discovery and research; computer database software for genome sequencing, annotation, interpretation and reporting, medical diagnosis and treatments, drug discovery and research; computer software for data analysis and reporting in the fields of life sciences, medicine and healthcare, namely, genome sequencing, medical diagnosis and treatments, drug discovery and research; computer software for genome sequencing, annotation, interpretation and reporting; computer software for potential patient identification and medical diagnosis based on genetic analysis; electronic computer databases in the fields of life sciences, medicine, healthcare, genome sequencing, annotation, interpretation and reporting, medical diagnosis and treatments and drug discovery and research, recorded on computer media; computer database servers; computer software for database management; computer software for creating searchable databases of information and data; online downloadable electronic publications in the nature of white papers, articles, magazines and brochures relating to the fields of life sciences, medicine and healthcareACTIVE—
035Database management; computer database management; database management, namely, managing and maintenance of data in computer databases relating to data collected from genome sequencing; computerised database management services; data management services, namely, collecting and managing data relating to genome sequencing, medical diagnosis and drug discovery; data processing management; compilation of data and information in computer databases; data processing and business analysis services; information, advisory and consultancy services in relation to all of the aforesaidACTIVE—
038Providing access to computer databases; operation of computer networks for accessing and sharing data, namely, transmission and distribution of data via a global computer network; information, advisory and consultancy services in relation to all of the aforesaidACTIVE—
042Scientific research and development services; design and development of databases; design and development of computer databases; database design and development services; computer database design and development services; research and development in the field of genomics; laboratory analysis, namely, genome interpretation and DNA sequencing services; providing software as a service featuring software for use in genome sequencing, annotation, interpretation and reporting; providing computer software platforms as a service featuring software for genome sequencing, annotation, interpretation and reporting; providing software as a service featuring software for use in potential patient identification and medical diagnosis based on genetic analysis; database reporting services, namely, creating reports relating to data collected from genome sequencing; installation, updating and maintenance of computer software; information, advisory and consultancy services in relation to all of the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Sep 14, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 14, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 14, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 14, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jun 29, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 29, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 6, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 13, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 13, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 13, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Jul 13, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 13, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 13, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 3, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 7, 2017DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Feb 3, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2017IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 24, 2017D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 6, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 11, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 11, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 21, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 7, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Sep 2, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 2, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 2, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 28, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2016ALIEASSIGNED TO LIE—
Jul 15, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2016DOCKASSIGNED TO EXAMINER—
Mar 24, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance